CLINICAL_TRIALS
trial_result
· 2012-11-22
Clinical Trial Update: Intermittent Versus Continuous Tarceva Study [Phase 2]
Summary
A Phase 2 trial comparing intermittent versus continuous Tarceva (erlotinib) in metastatic colorectal cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chinese University of Hong Kong | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED